Dextrose recalls

Dextrose products have been recalled 15 times, most recently on 29 Apr 2026. The recalling company is usually Baxter Healthcare. The most common reason is sterility.

Total recalls15since 2013

Last 12 months4reported

Class I533% of total

Ongoing5latest 29 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 4Apr 0 0 0Jul 0 0

Severity split

Class I 5 33%Class II 10 67%Class III 0 0%

Why dextrose is recalled

Companies

Product types

Injectable & IV Drugs15100%

By year

2026427%
202117%
201917%
2017213%
201617%
2015427%
201417%
201317%

Ongoing dextrose recalls

5 active

Reported	Class	Recall	Company	Reason	Where
29 Apr 2026Drug	CLASS II	Dextrose Injection recalled by B Braun MedicalDextrose	B Braun Medical	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
31 May 2017Drug	CLASS I	Infant 25% Dextrose Injection recalled by HospiraDextrose	Hospira	Particulate Matter	Nationwide

All dextrose recalls, newest first

15 total

Reported	Class	Recall	Company	Reason	Where
29 Apr 2026Drug	CLASS II	Dextrose Injection recalled by B Braun MedicalDextrose	B Braun Medical	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
8 Dec 2021Drug	CLASS II	5% Dextrose Injection, USP ADD-Vantage Unit recalled by PfizerDextrose	Pfizer	Sterility	Nationwide
18 Dec 2019Drug	CLASS II	25% Dextrose Injection, USP (250 mg/mL) Single-dose recalled by PfizerDextrose	Pfizer	Other	Nationwide
19 Jul 2017Drug	CLASS II	5% Dextrose Injection, USP Viaflex recalled by Baxter HealthcareDextrose	Baxter Healthcare	Foreign Material	Nationwide
31 May 2017Drug	CLASS I	Infant 25% Dextrose Injection recalled by HospiraDextrose	Hospira	Particulate Matter	Nationwide
15 Jun 2016Drug	CLASS I	Dextrose Injection,USP,70% Viaflex, Pharmacy recalledDextrose	Baxter Healthcare	Particulate Matter	Nationwide
15 Jul 2015Drug	CLASS I	10% Dextrose Injection, USP Viaflex recalled by Baxter HealthcareDextrose	Baxter Healthcare	Particulate Matter	PR

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.